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A defective-interfering (DI) RNA of mouse hepatitis virus (MHV) was developed as a vector for expressing MHV
hemagglutinin/esterase (HE) protein. The virus containing an expressed HE protein (A59-DE-HE) was generated by
infecting cells with MHV-A59, which does not express HE, and transfecting the in vitro-transcribed DI RNA containing
the HE gene. A similar virus (A59-DE-CAT) expressing the chloramphenicol acetyltransferase (CAT) was used as a
control. These viruses were inoculated intracerebrally into mice, and the role of the HE protein in viral pathogenesis was
evaluated. Results showed that all mice infected with parental A59 or A59-DE-CAT succumbed to infection by 9 days
postinfection (p.i.), demonstrating that inclusion of the DI did not by itself alter pathogenesis. In contrast, 60% of mice
infected with A59-DE-HE survived infection. HE- or CAT-specific subgenomic mRNAs were detected in the brains at
days 1 and 2 p.i. but not later, indicating that the genes in the DI vector were expressed only in the early stage of viral
infection. No significant difference in virus titer or viral antigen expression in brains was observed between A59-DE-HE-
and A59-DE-CAT-infected mice, suggesting that virus replication in brain was not affected by the expression of HE.
However, at day 3 p.i. there was a slight increase in the extent of inflammatory cell infiltration in the brains of the
A59-DE-HE-infected mice. Surprisingly, virus titers in the livers of A59-DE-HE-infected mice were 3 log10 lower than that
of the A59-DE-CAT-infected mice at day 6 p.i. Also, substantially less necrosis and viral antigen were detected in the
livers of the A59-DE-HE-infected mice. This may account for the reduced mortality of these mice. The possible
contribution of the host immune system to this difference in pathogenesis was analyzed by comparing the expression
of four cytokines. Results showed that both tumor necrosis factor-a and interleukin-6 mRNAs increased in the brains
of the A59-DE-HE-infected mice at day 2 p.i., whereas interferon-g and interleukin-1a mRNAs were similar between
A59-DE-HE- and A59-DE-CAT-infected mice. These data suggest that the transient expression of HE protein enhances
an early innate immune response, possibly contributing to the eventual clearance of virus from the liver. This study
indicates the feasibility of the DI expression system for studying roles of viral proteins during MHV infection. © 1998
Academic Press
INTRODUCTION
The development of infectious, full-length cDNA
clones of viral RNA has provided a powerful tool for
understanding the structure and function of individual
viral genes and for studying their roles in viral pathogen-
esis. Unfortunately, an infectious cDNA clone is currently
not available for some RNA viruses with a large genome,
such as coronaviruses. We have recently developed an
alternative approach, namely, a defective–interfering (DI)
RNA (Makino et al. 1985, 1988, 1991), which functions like
a minigenome, as an expression vector (Liao and Lai,
1994). Such a vector can express viral or foreign proteins,
including cytokines (Liao et al. 1995; Zhang et al. 1997),
thus allowing more critical analysis of the functional role
of these proteins in coronavirus pathogenesis.
Mouse hepatitis virus (MHV), a murine coronavirus, is
a member of the Coronaviridae. It contains a single-
strand, positive-sense RNA genome of 31 kb (Lee et al.
1991). In addition to the genomic-length RNA, six or
seven subgenomic mRNAs are synthesized in infected
cells. These RNAs are conested at the 39 end and extend
toward the 59 end to different lengths at intergenic (IG)
regions (Lai et al. 1981). Each mRNA contains a leader
RNA of approximately 70 nt at the 59 end, which is
identical to the leader of the genomic RNA (Lai et al.
1983, 1984). The IG sequence serves as an initiation site
and is required for the synthesis of a subgenomic mRNA.
In general, each mRNA translates only one protein from
the 59-most open reading frame (ORF) (Lai and Ca-
vanagh, 1997).
MHV contains four or five structural proteins. The
spike (S) protein is the major surface glycoprotein of the
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virion. It facilitates the attachment of virus to the cellular
receptors, elicits the production of neutralizing antibod-
ies, and induces cell fusion (Sturman and Holmes, 1983).
The membrane (M) glycoprotein is also associated with
the viral envelope and, together with another viral enve-
lope (E) protein, is required for virus assembly (Bos et al.
1996; Vennema et al. 1996). The nucleocapsid (N) protein
is a phosphorylated protein which together with the viral
genomic RNA forms the nucleocapsid. The hemaggluti-
nin/esterase (HE) protein is an optional envelope protein,
present only in some MHV strains (Yokomori et al. 1992).
It contains hemagglutination (receptor-binding) and acet-
ylesterase (receptor-destroying) activities, similar to the
HE protein of influenza C virus (Herrler et al. 1985, 1888;
Yokomori et al. 1989). The HE protein binds sialic acid-
containing cell surface molecules. The precise role of
the HE protein in coronaviral infection is not clear. It has
been shown that the HE protein of bovine coronavirus
induced the production of neutralizing antibodies and
that inhibition of the esterase activity resulted in a 100- to
400-fold reduction in viral infectivity, suggesting an im-
portant role of the HE protein in viral infectivity (Deregt
and Babiuk, 1987; Vlasak et al. 1988). In contrast, no
neutralizing antibody specific for the HE protein of MHV
has been identified (Yokomori et al. 1992), and expres-
sion of the HE protein alone, without the S protein, is not
sufficient to initiate MHV infection (Gagneten et al. 1995).
An MHV variant that expresses abundant HE appeared
to be more neurovirulent than the one that expresses
little HE (Yokomori et al. 1995). Consistent with these
data, passive immunization with HE monoclonal antibod-
ies protected mice from lethal infection and altered the
pathogenicity (Yokomori et al. 1992). These findings sug-
gest that the HE protein contributes to viral neuropatho-
genicity by influencing either the rate of virus spread,
viral tropism, or both (Yokomori et al. 1995). Although five
separate clonal populations expressing either high or
low levels of HE protein yielded identical results, no
precise role of the HE protein could be unequivocally
determined because these virus variants may contain
additional mutations in other viral genes.
In a previous study (Liao et al. 1995), we expressed the
HE protein of MHV in cell culture using the MHV-DI RNA
expression vector. In this system, the expression of the
HE-containing DI RNA requires the presence of a helper
MHV, and the expressed HE protein was shown to be at
least in part incorporated into the virions. However, due
to the lack of a specific packaging signal, the DI RNA
cannot be efficiently packaged into virus particles; it can
only be copackaged nonspecifically with the helper virus
particles for a limited number of cell culture passages.
The DI RNA eventually loses its association with the
helper virus and its ability to replicate during serial pas-
sages in cell culture. Therefore, the expression of the DI
RNA is transient and does not involve a recombination
between the helper virus genome and the DI RNA. In the
present study, we used this DI RNA vector system to
express the viral HE gene in the CNS of mice in the
presence of an HE-deficient helper virus. We found that
the transient expression of the HE protein by this vector
altered viral pathogenesis. This study thus demonstrates
unequivocally that HE protein plays a role in MHV patho-
genesis and further demonstrates the feasibility of using
this DI RNA vector for in vivo expression of a foreign
protein.
RESULTS
Expression of the HE gene alters virulence
It has previously been shown that MHV-A59 virus does
not express HE protein due to mutations in the transcrip-
tion start signal and coding sequence (Luytjes et al.
1988; Shieh et al. 1989). To assess the function of HE
protein, we were interested in determining if the expres-
sion of a functional HE gene derived from JHM virus by
the DI RNA vector could influence the pathogenesis of
A59 virus (Fig. 1). Mice were infected ic with 1 3 105 PFU
each of A59-DE-HE, A59-DE-CAT, or parental A59. Figure
2 shows that 100% of mice infected with A59-DE-CAT
succumbed to infection by day 9 postinfection (p.i.), sim-
ilar to mice infected with the parental A59 alone. These
data demonstrate that inclusion of DI RNA that ex-
presses a CAT gene did not by itself alter the outcome of
A59 infection. In contrast, 60% of mice infected with
A59-DE-HE virus survived infection. Mice infected with
all three virus preparations showed similar signs of en-
cephalitis (hunched back and ruffled fur) for the first 5 to
6 days p.i. Subsequently, clinical symptoms gradually
improved in those A59-DE-HE-infected mice that had
survived infection; by 12 to 14 days p.i., the clinical signs
were completely resolved and no mice subsequently
succumbed to infection. These data demonstrate that the
expression of the JHM virus HE gene by the DI RNA
vector substantially alters the pathogenesis of A59 virus
infection.
Expression of the HE gene in the CNS
We have previously shown that the expression of
genes from the DI vector can be maintained for only a
few passages in vitro (Liao et al. 1995). Thus, it was not
clear whether the HE protein could be expressed from
the DI vector within the CNS. To address this issue, RNA
was extracted from brains of infected mice at various
times p.i. and analyzed by RT–PCR using primers which
specifically detect HE-containing RNA (see Materials
and Methods). Since the HE-containing subgenomic
mRNA is transcribed from the IG site within the vector
RNA and contains a leader sequence at the 59 end, the
PCR product corresponding to the subgenomic HE
mRNA is distinguishable from that of the input DI RNA by
their size (Fig. 1). The result shows that the subgenomic
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HE mRNA was undetectable in RNA extracted from the
brains of infected mice at 12 h p.i. (data not shown);
however, it became detectable in RNA samples prepared
from the brains of A59-DE-HE-infected mice at 24, 36,
and 48 h p.i. (Table 1 shows data at 24 and 48 h p.i. only).
No HE mRNA was detected in RNA samples obtained on
day 4 or 6 p.i. Similarly, the mRNA encoding CAT could be
detected in A59-DE-CAT-infected mice only at 24, 36, and
48 h p.i. (Table 1). These data suggest that the HE or the
CAT gene indeed could be expressed from the DI RNA in
the brains during in vivo infection but that their expres-
sion was limited to the first 2 days p.i., consistent with its
limited ability to be serially passaged in vitro (Liao et al.
1995). Because of the low level of mRNA expression, the
amounts of HE- or CAT-specific mRNA were not quanti-
tatively compared.
Pathogenesis in the CNS following infection
with A59-DE-HE
To determine the basis for the reduction in mortality
following A59-DE-HE infection compared to other viruses
(Fig. 2), virus titers in the brains of mice infected with
A59-DE-HE were initially compared to mice infected with
the parental A59 or A59-DE-CAT at 6 days p.i. Based on
the survival of most mice infected with A59-DE-HE, re-
duced viral replication in the CNS was anticipated. How-
ever, only a slight (approximately 1 log10) reduction in
virus titer within the CNS was noted at 6 days p.i. in
A59-DE-HE-infected mice compared to mice infected
with either A59-DE-CAT or parental A59 (Table 1). We
reasoned that, since HE protein expression was detect-
able only early in infection, a more significant reduction
of virus titer in CNS might be detectable at an earlier time
of infection; thus, virus titers in the CNS of mice infected
with A59-DE-HE and A59-DE-CAT were compared at 1, 2,
and 4 days p.i. Similar to the titers found at 6 days p.i., no
significant difference was detected at any of the early
time points (Table 1). Therefore, although HE expression
in the CNS was detected for the first 2 days p.i., there
appeared to be no significant difference in virus replica-
tion in the CNS between A59-DE-HE- and A59-DE-CAT-
infected mice.
The pathogenicity of A59-DE-HE and A59-DE-CAT in
the CNS was then examined to determine the basis for
the difference in mortality between the two groups.
Brains and spinal cords were examined at 1, 2, 3, 4,
and 6 days p.i. for mononuclear cell infiltrates and
distribution of virus-infected cells. Consistent with the
similar amount of virus replication, no differences
were detected in either the extent or the distribution of
either mononuclear cell infiltration or viral antigen at 1
or 2 days p.i. in two separate experiments. However, at
FIG. 1. Diagram of the structure of pDE-HE. Only the genomic and subgenomic DI sequences are shown. The HE gene was placed behind the
coronavirus transcription promoter IG7. Positions and names of the primers (59-L9 and 39-HE or 39-HE74) used in RT–PCR to amplify genomic and
subgenomic mRNAs (shown on the right) in tissues of mice infected with DE-HE-containing MHV-A59. The sizes of the HE-containing DI genomic and
subgenomic RNAs are indicated in kilobases below the sequences. The solid arrow indicates the transcription start site from the IG7 sequence.
FIG. 2. Survival rate of mice following infection with A59-DE-HE,
A59-DE-CAT, or A59. Eight-week-old C57BL/6 mice (7 mice per group)
were intracerebrally inoculated with A59-DE-HE or A59-DE-CAT or A59
(105 PFU/mouse) and observed daily for clinical symptoms and sur-
vival.
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3 days p.i., there was a slight but reproducible in-
crease in the extent of inflammatory cell infiltration
and reduced viral antigen in the mice infected with
A59-DE-HE compared to mice infected with A59-DE-
CAT (Fig. 3). Quantitation of viral antigen-positive cells
revealed approximately one-third fewer positive cells
in the A59-DE-HE-infected mice than in those in A59-
DE-CAT-infected mice. This difference was no longer
noticeable by 6 days p.i. These data suggest that
expression of the HE gene within the CNS resulted in
a transient increase in CNS inflammation and reduc-
tion in viral antigen. This difference was transient and
minor and did not appear sufficient to explain the
increased survival of mice infected with A59-DE-HE.
Survivors of A59-DE-HE infection examined at 21 days
p.i. showed mononuclear cell infiltrations, presence of
viral antigen, and extensive demyelination, consistent
with the pathology reported for mice infected with
sublethal doses of parental A59 (Lavi et al. 1984).
To ensure that the altered pathogenesis of A59-
DE-HE was due to transient HE expression but not to
the selection of a variant A59 virus, virus was recov-
ered from A59-DE-HE-infected mice at 6 days p.i. This
time point was chosen based on the absence of de-
tectable HE gene expression in the CNS. Virus iso-
lated (designated A59-R) was propagated once in DBT
cells and used to infect mice using the same dose as
that in the previous experiments (1 3 105 PFU). All
mice infected with this virus succumbed to infection by
day 9. Furthermore, the amount of virus present in the
CNS of these mice at day 6 was equivalent to the virus
detected in mice infected with A59-DE-HE, A59-DE-
CAT, or parental A59 (Table 1). These combined data
suggest that the difference in mortality following ic
infection with A59-DE-HE was not due to alterations in
virus replication within the CNS, altered cellular tro-
pism, or selection of an attenuated variant.
Viral replication and pathology in the liver
in A59-DE-HE infection
The A59 strain of MHV is both neurotropic and hepa-
totropic (Lavi et al. 1986). Since differences in virus rep-
lication and pathogenesis of A59-DE-HE in the CNS did
not appear to be sufficient to account for the differences
in mortality, we explored the possibility that the de-
creased mortality in A59-DE-HE-infected mice was due
to altered hepatotropism. Therefore, virus replication and
pathological changes in the livers of mice infected with
A59-DE-HE and A59-DE-CAT were compared. Table 2
shows that at day 1 p.i., there was approximately 1 log10
less infectious virus recovered from the liver of mice
infected with A59-DE-HE than from mice infected with
A59-DE-CAT. However, no differences in virus replication
were found at either day 2 or 4 p.i. Surprisingly, by day
6 p.i., when the A59-DE-CAT-infected mice were begin-
ning to succumb to infection, there was a substantial
reduction (3 log10) in the amount of infectious virus in the
liver of A59-DE-HE-infected mice (Table 2). This differ-
ence was reproducible in three independent experi-
ments. Histological examination of the livers of mice
infected with A59-DE-CAT showed increasing viral anti-
gen and inflammatory changes with time throughout the
infection. By day 6 p.i., the livers of these mice showed
evidence of extensive necrosis with prominent viral an-
tigen (Figs. 4A and 4B). Similar hepatic necrosis was
found following ic infection with both parental A59 and
A59-R (data not shown). A59-DE-HE-infected mice also
showed similar inflammatory changes, hepatic necrosis,
and viral antigen in the livers at day 1 or 2 p.i., compared
to A59-DE-CAT-infected mice. However, by day 3 p.i.,
fewer viral antigen-positive cells and reduced necrosis
were noted in mice infected with A59-DE-HE. By day
6 p.i., there was a significant reduction in the amount of
viral antigen (Fig. 4D), consistent with decreased titer of
infectious virus (Table 2) and substantially less necrosis
(Fig. 4C), in contrast to the almost confluent necrosis
TABLE 1
Virus Replication in the CNS Following Intracerebral Inoculation of Mice with the HE-Expressing and Control Viruses
Daya
A59-DE-HE A59-DE-CAT A59 A59-Rd
PCRb Titerc PCR Titer Titer Titer
1 1 4.59 6 0.16 (5) 1 5.05 6 0.44 (5) NDe ND
2 1 5.66 6 0.34 (5) 1 5.27 6 0.66 (5) ND ND
4 2 5.45 6 0.14 (3) 2 5.43 6 0.45 (3) ND ND
6 2 4.58 6 0.98 (9) 2 5.62 6 1.01 (6) 5.12 6 0.65 (3) 5.76 6 0.35 (3)
a Day(s) postinfection. Mice were infected ic with 1 3 105 PFU of various viruses.
b RT–PCR detecting the subgenomic mRNA expressed from the DI RNA.
c Mean titer in PFU/g brain, in log10 6 standard deviation (number/group).
d Virus recovered from the CNS of mice at day 6 following infection with A59-DE-HE.
e Not done.
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FIG. 3. Detection of viral antigen and histopathologic changes in the brains of mice infected ic with A59-DE-CAT or A59-DE-HE. In (A), 3 days after
infection with A59-DE-CAT, sections of brain show small foci of chronic inflammation (arrowhead) with multiple foci of antigen-positive cells (arrows).
At higher magnification (B), the foci demonstrate a mixed population of virus-positive cells. In (C), 3 days after infection with A59-DE-HE, sections of
brain show increased subarachnoid and perivascular inflammatory infiltrates (arrowheads) but fewer virus-positive cells (arrows). At higher
magnification (D), a mixed population of virus-positive cells is seen. Immunoperoxidase stain by the ABC method for viral antigen (using N-specific
mAb J.3.3) with hematoxylin counterstain. Magnifications: 340 (A, C), 3440 (B, D).
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found in the mice infected with either parental A59 or
A59-DE-CAT (Figs. 4A and 4B). Again, the A59 virus
(A59-R) recovered from the CNS at day 6 p.i. did not differ
from the original A59 virus. These data suggest that the
transient expression of the HE gene in the CNS affected
the virus replication and subsequent pathology in the
liver. This is likely the basis for the reduced mortality of
A59-DE-HE-infected mice.
FIG. 3—Continued
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To determine if the activation of the mouse fibrino-
gen-like protein (fgl-2) gene was associated with the
fulminent hepatitis induced by ic infection with the
A59-DE-CAT virus, as has been shown to be the case
in the hepatitis induced by MHV-3 (Parr et al. 1995),
livers were examined for the presence of fgl-2 gene
mRNA by RT–PCR. No difference in expression of
fgl-2 mRNA was detected between A59-DE-HE- and
A59-DE-CAT-infected mice (data not shown). Histo-
logic examination of the livers did not reveal coagu-
lopathy typically induced by MHV-3 infection (Parr et
al. 1995).
We next examined the virus titers in the spleen follow-
ing ic infection to determine if the difference in virus titer
in the livers of A59-DE-HE-infected mice was due to a
difference in virus spread from the CNS. A slight reduc-
tion in virus titer in the spleens of mice infected with
A59-DE-HE on day 1 p.i. was found compared to mice
infected with A59-DE-CAT (Table 3). However, no differ-
ence was detected at day 2 or 4 p.i., and no infectious
virus could be recovered from the spleens of either
group by day 6 p.i. (Table 3). These data suggest that A59
replicated poorly and only transiently in the spleen fol-
lowing ic infection; nevertheless, this small amount of
virus in the spleen may have spread to the liver via a
hematogenous route. Therefore, A59-DE-HE and A59-
DE-CAT appeared to spread similarly from the CNS to
spleen and liver.
To determine if A59-DE-HE exhibited reduced hepa-
totropism, compared to A59-DE-CAT and parental A59,
we examined virus replication in the liver following
intraperitoneal (ip) infection. Groups of four mice were
infected with 1 3 105 PFU of each virus ip. Surpris-
ingly, at 6 days p.i., no infectious virus was recovered
from the livers or CNS of any of the three groups and
no evidence of hepatitis or viral antigen was detected
(data not shown). These data indicate that in contrast
to previous data (Lavi et al. 1986), none of these three
virus preparations are directly hepatotropic following
ip infection.
Cytokine mRNA expression
To correlate early, transient HE protein expression
with the observed alterations in mononuclear cell infil-
trates, expression of various cytokine mRNAs in the CNS
and liver were examined at 2 days p.i. This time point
was chosen since it was the last time point p.i. when HE
mRNA could be detected (Table 1). Increased expression
of the mRNAs encoding TNF-a was detected in the CNS
of A59-DE-HE-infected mice compared to samples from
mice infected with the A59-DE-CAT virus (Fig. 5A). The
TNF-a mRNA expression in the liver showed a similar
trend, although the level of this mRNA in the liver was
lower than that in the CNS (Fig. 5A). IL-6 mRNA was also
increased in the CNS of mice infected with A59-DE-HE
virus (Fig. 5B); however, no differences were detected in
the liver between the two groups. Although the level of
IFN-g mRNA was very low in the tissues from both
groups, a slight decrease in IFN-g mRNA was detected
in the CNS but not in the livers of mice infected with the
A59-DE-HE virus (Fig. 5C). No difference was found in
the expression of IL-1a mRNA in either CNS or liver (Fig.
5D). These data indicate that the transient expression of
the HE protein resulted in the early induction of both
TNF-a and IL-6 mRNA in the CNS.
DISCUSSION
The HE protein is expressed only by some strains of
MHV (Yokomori et al. 1991); thus, it is not required for
viral replication. During virus passage in tissue culture or
in animals, the HE gene often undergoes mutation so
that the virus loses the ability to synthesize HE protein
(Yokomori et al. 1991). However, reverse changes have
also occurred; for example, a JHM variant, which has
three repeats of the UCUAA pentanucleotide at the 39
end of the leader sequence (Makino and Lai, 1989) and
synthesized a very small amount of HE, generated, upon
passage, a JHM variant containing two repeats of the
UCUAA pentanucleotide, resulting in expression of a
large amount of HE protein (Makino and Lai, 1989; Shieh
et al. 1989; Yokomori et al. 1989; La Monica et al. 1992).
TABLE 2
Virus Replication in the Liver Following Intracerebral Inoculation of Mice with the HE-Expressing and Control Viruses
Daya
Virus titerb
A59-DE-HE A59-DE-CAT A59 A59-R
1 1.32 6 1.43 (5) 2.45 6 0.82 (5) NDc ND
2 3.68 6 1.06 (5) 3.98 6 0.52 (5) ND ND
4 4.85 6 0.28 (3) 5.41 6 0.32 (3) ND ND
6 1.51 6 1.57 (9) 4.64 6 0.40 (6) 5.31 6 0.40 (3) 5.81 6 0.12 (3)
a Day(s) postinfection. Mice were infected ic on day 0 with 1 3 105 PFU.
b Mean titer in PFU/g liver, in log10 6 standard deviation (number/group).
c Not done.
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Initial demonstration that HE may play a role in viral
neuropathogenesis was obtained from studies showing
that passive transfer of anti-HE monoclonal antibodies
protected mice from lethal infection by JHM viruses ex-
pressing various amounts of HE, but not a JHM variant
which expressed no HE (Yokomori et al. 1992). His-
topathological studies of the HE-protected mice sug-
gested that an early mononuclear infiltration into the
CNS was associated with the protection by this mono-
clonal antibody. Subsequent comparisons of the patho-
genicity of the JHM variants expressing different levels of
HE demonstrated that the JHM variant which expresses
high levels of HE replicated less efficiently in glial cells in
vitro and preferentially infected neurons in vivo (Yokomori
et al. 1995). Together, these data suggested that HE
protein is at least one of the factors influencing the
neuropathogenesis of JHM in the CNS. However, the
effect of HE protein on viral pathogenesis may depend
on the genetic background of the virus. This question
was difficult to assess in the previous studies since JHM
variants used in those studies may differ not only in HE
gene expression but also in other unscrutinized viral
genes as well. In this report, we examined the influence
of HE protein on neuropathogenesis of the A59 strain of
MHV using a DI vector approach, so that the presence or
the absence of HE can be studied on the same virus
background. A59 was chosen because its pathogenesis
in mice has been well described (Lavi et al. 1984, 1986)
and it does not produce any background level of the HE
protein due to a mutation in the transcription start signal
and a premature stop codon in the HE gene (Luytjes et
al. 1988; Shieh et al. 1989). Our data showed that expres-
sion of the HE gene from the DI vector did indeed alter
the pathogenesis of A59 infection by increasing the sur-
vival rate of the infected mice when compared to either
parental A59 or A59 containing a CAT-expressing DI RNA
(A59-DE-CAT). However, this higher survival rate was
apparently due to the reduction in liver pathology. In the
CNS, the expression of HE by DI RNA resulted in only a
slight and transient increase of mononuclear cell infiltra-
tion and no alteration in cellular tropism. The apparent
differences between this DI-expressed HE and the HE
expressed directly from the virus was probably due to the
transient nature of HE expression by the DI RNA, while
the latter was expressed continuously throughout the
infection. Nevertheless, this study shows that even tran-
sient expression of the HE protein can alter viral patho-
genicity.
These data removed two constraints upon the use of
DI vector for expressing foreign proteins during viral
infections. First, expression of an irrelevant gene from
the DI RNA during infection did not alter pathogenesis of
the virus. This suggests that the weak interference ac-
tivity exhibited by DI RNA in vitro (Makino et al. 1985)
plays very little role during virus infection in vivo. Second,
the conservation of wild-type virus after the DI RNA had
been lost suggested that the presence of DI RNA did not
result in the selection of a variant virus, which potentially
could have been derived by RNA recombination, either
during in vitro preparation of the DI RNA-containing virus
or during subsequent in vivo replication.
The A59 strain of MHV is a dual tropic virus, infecting
both the CNS and liver following ic or intranasal infection
(Lavi et al. 1986). At low infectious doses, the hepatitis
usually resolves and survivors develop extensive chronic
demyelination within the CNS (Lavi et al. 1984). Our data
using a relatively large infecting dose show that mice
infected with the parental A59 or A59-DE-CAT or A59-
DE-HE virus succumb to the infection most likely due to
hepatic necrosis, since there was only relatively mild
CNS pathology at the time of death of the infected mice.
Because virus replication in the liver and spleen early in
infection was similar between A59-DE-HE- and A59-DE-
CAT-infected mice, it is unlikely that there was a funda-
mental difference in hepatotropism between these two
viruses. Therefore, the striking resolution of hepatitis and
the reduction in infectious virus in mice infected with
A59-DE-HE at day 6 p.i. suggests that an early function of
the innate immune response is most likely responsible
for this phenomenon. It is worthy of note that no CD41 or
CD81 T cell epitopes have been detected within the HE
gene (Bergmann et al. 1996; Van der Veen, 1996). In
addition, there is no detectable anti-MHV antibody in the
serum at the time when the hepatitis resolves (Parra et
al. 1997).
Together, these data suggest that HE gene expression
may activate or enhance a function of nonspecific innate
immunity. Consistent with this notion, increased levels of
TNF-a and IL-6 mRNA were detected in the CNS of mice
infected with A59-DE-HE. Although TNF-a mRNA has
previously been demonstrated to increase in the CNS
following infection with the JHM strain of MHV (Pearce et
al. 1994; Parra et al. 1997), inhibition of TNF has no effect
on either virus clearance or CNS mononuclear cell infil-
tration (Stohlman et al. 1995). Therefore, the potential
role of increased TNF-a mRNA expression following ex-
pression of the HE protein is not clear. Increased IL-6
mRNA, another pleotropic cytokine (Van Snick, 1990),
was also detected in the CNS of A59-DE-HE-infected
mice. IL-6 is secreted from both endothelial cells and
astrocytes following MHV infection (Joseph et al. 1993)
and IL-6 mRNA peaks rapidly in the CNS following MHV
infection as a direct consequence of the immune re-
sponse to infection (Parra et al. 1997). Based on a kinetic
analysis of IL-6 mRNA induction in the CNS following
MHV infection (Parra et al. 1997), IL-6 has been sug-
gested to play a role in the inflammatory response via
enhanced recruitment of mononuclear cells and activa-
tion of acute phase responses in addition to its role as a
cofactor for CTL induction (Romano et al. 1997; Kopf et al.
1994). Increased IL-6 mRNA present in the CNS of mice
infected with A59-DE-HE virus is consistent with the
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FIG. 4. Detection of viral antigen and histopathologic changes in the livers of mice infected ic with A59-DE-CAT or A59-DE-HE. In (A), 6 days after
infection with A59-DE-CAT, sections of liver show large confluent foci of necrosis (arrowheads) with many virus-positive hepatocytes (arrows), seen
in (B) at higher magnification. In (C), 6 days after infection with A59-DE-HE, sections of liver show only rare foci of hepatic necrosis. While some foci
are antigen-negative, other foci show rare antigen-positive cells (arrow) (D). Immunoperoxidase stain by the ABC method for viral antigen (using
N-specific mAb J.3.3) with hematoxylin counterstain. Magnifications: 3110 (A, C); 3440 (B, D).
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increased mononuclear cell infiltration at a time during
infection (day 3 p.i.) prior to detectable virus-specific
immunity. These data support the suggestion that HE
protein expression enhances the innate immune re-
sponse, contributing to the eventual clearance of virus
from the liver.
This study and the previous report of the expression of
IFN-g (Zhang et al. 1997) using a MHV-DI RNA vector
FIG. 4—Continued
179A DI RNA OF MHV THAT EXPRESSES HE PROTEIN
system indicate the feasibility of this system for studying
roles of viral proteins or cytokines during MHV infection.
Although expression of proteins is transient and local-
ized at the sites of viral infection, these features may
actually offer advantages in studying viral pathogenesis.
MATERIALS AND METHODS
Mice
C57BL/6 mice were purchased from The Jackson Lab-
oratories (Bar Harbor, ME) at 6–7 weeks of age. Mice
were housed locally in microisolator cages and were
used within 7 days of receipt. None were found to have
preexisting anti-MHV antibodies prior to use. Mice were
inoculated intracranially (ic) with 1 3 105 plaque-forming
units (PFU) of virus in 30 ml of Dulbecco’s phosphate-
buffered saline (DPBS).
Viruses and cells
MHV strain A59 was used throughout the study. It was
originally obtained from Dr. Cliff Bond of University of
California, San Diego (Leibowitz et al. 1981), plaque-
purified four times, and used within eight passages of
purification. The murine astrocytoma cell line DBT
(Hirano et al. 1974) was used for virus propagation,
plaque assay, and preparation of DI stocks.
Construction of DI vector
To construct a DI vector containing the HE gene, we
used p25CAT (Liao and Lai, 1994), which contains a CAT
gene behind the (IG) sequence of gene 7 (IG7) in the
cDNA of DIssE RNA (Makino et al. 1988) as a starting
plasmid. The cDNA of the HE gene was generated by
reverse transcription–polymerase chain reaction (RT–
PCR) amplification using the cytoplasmic RNAs from
MHV-JHM-infected cells as templates and two primers,
59-HE (59-GGG ACT AGT ATT GTT GAG AAT CTA ATC
TAA ACT TTA AGG AAT GGG CAG TAC GTG C-39) and
39-HE (59-GGG CTG CAG TTA TGC CTC ATG CAA TCT-
39), corresponding to the ends of the HE gene plus SpeI
and PstI (italicized sequences). Following restriction en-
zyme digestion with SpeI and PstI, a 1.4-kb cDNA con-
taining the complete HE gene sequence was purified
from low-melting-point agarose gel and cloned into the
SpeI and PstI sites of p25CAT to replace the CAT gene
(Liao and Lai, 1994), resulting in pDE-HE (Fig. 1).
Preparation of DI stock viruses
For making DI stock viruses, plasmid DNAs of pDE-HE
and p25CAT were linearized with restriction enzyme XbaI
and subjected to in vitro transcription. The in vitro tran-
scription was carried out in a reaction containing 13
transcription buffer (Promega, Madison, WI), 10 mM di-
thiothreitol (DTT), 1 U/ml RNasin, 0.5 mM each ATP, CTP,
UTP, and GTP, 5 mg linearized DNA of pDE-HE or
p25CAT, and 40 U T7 RNA polymerase at 37°C for 2 h
according to the procedure recommended by the manu-
TABLE 3
Virus Replication in the Spleen Following Intracerebral Inoculation
of Mice with the HE-Expressing and Control Viruses
Daya
Virus titerb
A59-DE-HE A59-DE-CAT
1 0.19 6 0.42 (5) 1.08 6 1.00 (5)
2 1.28 6 1.55 (5) 0.44 6 0.62 (3)
4 1.33 6 0.65 (5) 1.03 6 1.08 (3)
6 Not detectable Not detectable
a Day(s) postinfection. Mice were infected ic with 1 3 105 PFU of
various viruses on day 0.
b Mean titer in PFU/g spleen, in log10 6 standard deviation (number/
group).
FIG. 5. Expression of TNF-a (A), IL-6 (B), IFN-g (C), and IL-1a (D) mRNAs in the CNS and livers of mice infected with A59-DE-HE or A59-DE-CAT
at 2 days p.i.
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facturer (Promega). The in vitro-transcribed RNA was
transfected into MHV-A59-infected DBT cells using the
DOTAP method (Boehringer-Mannheim, Indianapolis,
IN). Briefly, monolayers of DBT cells at approximately
80% confluence in 60-mm petri dishes were infected with
A59 at a m.o.i. of 5. At 1 h postinfection (p.i.), virus-
infected cells were washed once with serum-free Eagle’s
minimal essential medium (MEM) and then covered with
2 ml of MEM containing 1% newborn calf serum. Ten
micrograms of in vitro-transcribed RNA was mixed with
DOTAP (Boehringer-Mannheim) in 13 HBS buffer (20
mM HEPES; 150 mM NaCl; pH 7.4). The RNA–DOTAP
mixture was incubated at room temperature for 10 min
and then added slowly to the cell culture. At 12 to 14 h
posttransfection, culture medium was harvested and cell
debris removed by low-speed centrifugation. Superna-
tants were used as DI stocks. Each DI stock consisted of
a mixture of virus populations (helper virus alone, helper
virus containing HE protein on the surface, and helper
virus containing a copackaged DI genomic RNA); only
the virus with a copackaged DI RNA could synthesize the
HE protein. Prior to inoculation into animals, virus titers
of the DI stocks were determined by plaque assay using
DBT cells as previously described (Fleming et al. 1983).
The titers were 7.5 3 107 for A59-DE-CAT and 8.0 3 107
for A59-DE-HE. The replication of the DI RNAs of these
stock viruses in DBT cells was determined by RT–PCR
(Zhang et al. 1997) and was shown to be similar. The
expression of the HE and CAT proteins in DBT cells was
confirmed by immunoprecipitation using an anti-HE an-
tibody (Yokomori et al. 1992) and CAT assay (Zhang et al.
1994), respectively. These DI stocks were then used to
inoculate mice intracerebrally at 1 3 105 PFU per animal.
Determination of virus titers in tissues
Virus titers in mouse tissues were determined by ho-
mogenization of one half of the brain or liver lobe in 4.0
ml of DPBS, pH 7.4, using Tenbrock tissue homogenizers.
The remainder was processed for histopathology (see
below). Following centrifugation of the tissue homoge-
nates at 1500 g for 20 min at 4°C, supernatants were
assayed immediately or frozen at 270°C. Virus titers
were determined by plaque assay using monolayers of
DBT cells as previously described (Fleming et al. 1983).
Data were presented as the average log10 titer per gram
of tissue for groups of three or more mice.
RNA isolation and RT–PCR analysis
RNAs were isolated from tissues with the Trizol Re-
agent according to the manufacturer’s instruction (Life
Technologies, Grand Island, NY). Briefly, approximately
0.1 g of tissue was homogenized in 1 ml Trizol Reagent
using a glass–Teflon homogenizer. Following incubation
of the homogenized sample for 5 min at room tempera-
ture, 0.2 ml of chloroform was added to each sample.
RNAs were separated by centrifugation at 12,000 g for 15
min at 4°C, precipitated with ethanol, and resuspended
in water.
For detection of the mRNA species representing HE
and CAT genes, RNA samples were subjected to reverse
transcription (RT) using primers 39-HE and 39-CAT542
(Liao and Lai, 1994), respectively. cDNAs were amplified
by nested PCR (95°C, 1 min for denaturing; 59°C, 30 s for
annealing; 72°C, 2 min for extension). The primer pairs
59-L9 (specific to the leader RNA, Zhang et al. 1994)/
39-HE for the HE gene and 59-L9/39CAT542 for the CAT
gene were used for the first PCR and 59-L9/39-HE74
(Zhang and Lai, 1994) or 59-L9/39-CAT106 (Zhang et al.
1994), respectively, for the second PCR. Each PCR was
carried out for 25 cycles. These PCRs would amplify both
the full-length DI RNA (3.6 kb for DE-HE and 2.9 kb for
DE-CAT) and the subgenomic mRNAs representing HE
and CAT genes (2.1 kb for DE-HE and 1.4 kb for DE-CAT).
The PCR products were analyzed by agarose gel elec-
trophoresis and visualized by ethidium bromide staining.
The nature of the PCR product representing the sub-
genomic mRNA was confirmed by the size and the re-
striction patterns of the PCR products.
For detection of the gene coding for the mouse fibrin-
ogen-like protein (fgl-2, formerly named musfiblp), RT–
PCR was carried out using the antisense primer 1423B
(59-TAA ACA GTA AGT GAA TTA CCA C-39, complemen-
tary to nucleotide positions 2063–2084) and the sense
primer 1423A (59-ATG GGT GGA GGC TGG ACG GT-39,
corresponding to nucleotide positions 861–880) (Parr et
al. 1995). Primers were kindly provided by Dr. Julian
Leibowitz (University of Texas A & M). For cytokine mRNA
expression, RNAs were reverse-transcribed using AMV
reverse transcriptase and oligo(dT) primers (Promega,
Madison, WI). The cDNAs were amplified by PCR using
oligonucleotide primers specific for interferon-g (IFN-g),
tumor necrosis factor (TNF)-a, interleukin (IL)-6, and
IL-1a (Cua et al. 1995; Parra et al. 1997). PCR products
were quantitated by dot blot assays of serial dilution
using specific [g-32P]ATP-labeled oligonucleotide probes
as previously described (Cua et al. 1995; Parra et al.
1997). Signal intensities were measured using a Phos-
phor Imager scanner (Molecular Dynamics, Sunnyvale,
CA). Values obtained for the cytokine mRNAs were nor-
malized to the housekeeping enzyme hypoxanthine
phosphoribosyltransferase (HPRT) mRNA values ob-
tained in parallel experiments to compensate for varia-
tions in input cDNA. Data are expressed as the relative
values of the maximum obtained for individual samples.
Histopathology
For routine histopathological analysis, mice were sac-
rificed by CO2 asphyxiation. Brains were removed and
dissected in the midcoronal plane. The side of the brain
opposite the needle track was taken for immunohisto-
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chemical study in all cases. Brain hemispheres, spinal
cords, and livers were fixed for 3 h in Clark’s solution
(75% ethanol and 25% glacial acetic acid) and embedded
in paraffin. For routine analysis of brain sections a single
coronal section including cerebellum, brain stem, hip-
pocampus, and olfactory cortex was used. The same
region of the brain was examined in all animals. At
critical time points (e.g., day 3 p.i.) five step sections
were taken through each hemisphere and stained for
viral antigen. All viral antigen-positive cells were counted
in each section and summed for each animal. Sections
were stained with hematoxylin and eosin for microscopic
examination. The distribution of viral antigen was exam-
ined using immunoperoxidase staining (Vectastain-ABC
kit, Vector Laboratories, Burlingame, CA) and anti-JHMV
monoclonal antibody mAb J.3.3 specific for the carboxy
terminus of the N protein (Fleming et al. 1983). All slides
were read in a blinded manner.
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